Variant report
Variant | nsv4371 |
---|---|
Chromosome Location | chr4:69046637-69081620 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:86)
- CpG islands (count:549)
- Chromatin interactive region (count:6)
- LncRNA region (count:8)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr4:69046738-69047214 | Hela-S3 | cervix: | n/a | n/a |
2 | CBX3 | chr4:69074794-69075040 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr4:69046925-69047238 | MCF-7 | breast: | n/a | n/a |
4 | CEBPB | chr4:69046723-69047292 | Hela-S3 | cervix: | n/a | n/a |
5 | CEBPB | chr4:69049103-69049471 | HepG2 | liver: | n/a | chr4:69049268-69049279 |
6 | CEBPB | chr4:69049105-69049380 | A549 | lung: | n/a | chr4:69049268-69049279 |
7 | CEBPB | chr4:69049084-69049619 | Hela-S3 | cervix: | n/a | chr4:69049268-69049279 |
8 | CEBPB | chr4:69046736-69047277 | HCT-116 | colon: | n/a | n/a |
9 | CHD2 | chr4:69046647-69047188 | Hela-S3 | cervix: | n/a | n/a |
10 | CTCF | chr4:69074090-69074132 | LNCaP | prostate: | n/a | n/a |
11 | CTCF | chr4:69048275-69048355 | Fibrobl | skin: | n/a | n/a |
12 | E2F4 | chr4:69079381-69079750 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | E2F4 | chr4:69046596-69046811 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | EP300 | chr4:69046809-69047360 | ECC-1 | luminal epithelium: | n/a | n/a |
15 | EP300 | chr4:69046724-69047277 | Hela-S3 | cervix: | n/a | n/a |
16 | EP300 | chr4:69049104-69049524 | Hela-S3 | cervix: | n/a | n/a |
17 | EP300 | chr4:69046742-69047412 | ECC-1 | luminal epithelium: | n/a | n/a |
18 | ESR1 | chr4:69051178-69051380 | T-47D | breast: | n/a | n/a |
19 | ESR1 | chr4:69051083-69051344 | T-47D | breast: | n/a | n/a |
20 | ESR1 | chr4:69051046-69051355 | T-47D | breast: | n/a | n/a |
21 | FOS | chr4:69049230-69049530 | MCF10A-Er-Src | breast: | n/a | chr4:69049450-69049460 |
22 | FOS | chr4:69046607-69047219 | MCF10A-Er-Src | breast: | n/a | chr4:69047007-69047016 |
23 | FOS | chr4:69046570-69047308 | MCF10A-Er-Src | breast: | n/a | chr4:69047007-69047016 |
24 | FOS | chr4:69049253-69049599 | MCF10A-Er-Src | breast: | n/a | chr4:69049450-69049460 |
25 | FOS | chr4:69049233-69049535 | MCF10A-Er-Src | breast: | n/a | chr4:69049450-69049460 |
26 | FOS | chr4:69046573-69047258 | MCF10A-Er-Src | breast: | n/a | chr4:69047007-69047016 |
27 | FOS | chr4:69046652-69047284 | MCF10A-Er-Src | breast: | n/a | chr4:69047007-69047016 |
28 | FOSL2 | chr4:69046793-69047283 | A549 | lung: | n/a | chr4:69047007-69047016 |
29 | FOXA1 | chr4:69050707-69051016 | T-47D | breast: | n/a | n/a |
30 | FOXA2 | chr4:69060058-69060523 | A549 | lung: | n/a | n/a |
31 | GATA3 | chr4:69074527-69074719 | SH-SY5Y | brain: | n/a | n/a |
32 | GATA3 | chr4:69051056-69051593 | MCF-7 | breast: | n/a | n/a |
33 | GATA3 | chr4:69050943-69051653 | MCF-7 | breast: | n/a | n/a |
34 | GATA3 | chr4:69051216-69051374 | MCF-7 | breast: | n/a | n/a |
35 | JUN | chr4:69077787-69077958 | K562 | blood: | n/a | n/a |
36 | JUND | chr4:69046571-69047177 | Hela-S3 | cervix: | n/a | chr4:69047007-69047016 |
37 | KAP1 | chr4:69074668-69075268 | K562 | blood: | n/a | n/a |
38 | MAFF | chr4:69058968-69059260 | HepG2 | liver: | n/a | chr4:69059110-69059124 chr4:69059111-69059129 |
39 | MAFF | chr4:69059001-69059282 | K562 | blood: | n/a | chr4:69059110-69059124 chr4:69059111-69059129 |
40 | MAFF | chr4:69049114-69049419 | HepG2 | liver: | n/a | n/a |
41 | MAFK | chr4:69058977-69059269 | HepG2 | liver: | n/a | chr4:69059109-69059125 chr4:69059113-69059123 chr4:69059110-69059124 chr4:69059107-69059127 |
42 | MAFK | chr4:69049211-69049336 | IMR90 | lung: | n/a | n/a |
43 | MAFK | chr4:69049131-69049533 | HepG2 | liver: | n/a | n/a |
44 | MAFK | chr4:69059002-69059252 | K562 | blood: | n/a | chr4:69059109-69059125 chr4:69059113-69059123 chr4:69059110-69059124 chr4:69059107-69059127 |
45 | MAFK | chr4:69058957-69059288 | IMR90 | lung: | n/a | chr4:69059109-69059125 chr4:69059113-69059123 chr4:69059110-69059124 chr4:69059107-69059127 |
46 | MAFK | chr4:69058948-69059296 | HepG2 | liver: | n/a | chr4:69059109-69059125 chr4:69059113-69059123 chr4:69059110-69059124 chr4:69059107-69059127 |
47 | MAFK | chr4:69049130-69049419 | HepG2 | liver: | n/a | n/a |
48 | MAZ | chr4:69046655-69046775 | Hela-S3 | cervix: | n/a | n/a |
49 | MYC | chr4:69046958-69047218 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | MYC | chr4:69046815-69047230 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:69048335-69048385 | HEEpiC | esophagus: | n/a |
2 | chr4:69052173-69052223 | HMEC | breast: | n/a |
3 | chr4:69046856-69046906 | HEEpiC | esophagus: | n/a |
4 | chr4:69048233-69048283 | HCT-116 | colon: | n/a |
5 | chr4:69048156-69048206 | HEEpiC | esophagus: | n/a |
6 | chr4:69048233-69048283 | SK-N-MC | brain: | n/a |
7 | chr4:69048156-69048206 | AG09309 | skin: | n/a |
8 | chr4:69046856-69046906 | SK-N-MC | brain: | n/a |
9 | chr4:69047758-69047808 | GM19239 | blood: | n/a |
10 | chr4:69047758-69047808 | AG04450 | lung: | fetal |
11 | chr4:69048233-69048283 | IMR90 | lung: | fetal |
12 | chr4:69048156-69048206 | HPAEpiC | pulmonary alveolar: | n/a |
13 | chr4:69052173-69052223 | HCT-116 | colon: | n/a |
14 | chr4:69046856-69046906 | SK-N-SH | brain: | n/a |
15 | chr4:69048430-69048480 | Hepatocyte | liver: | n/a |
16 | chr4:69048430-69048480 | SK-N-MC | brain: | n/a |
17 | chr4:69054755-69054805 | LNCaP | prostate: | n/a |
18 | chr4:69048335-69048385 | GM12878 | blood: | n/a |
19 | chr4:69048233-69048283 | HCM | heart: | n/a |
20 | chr4:69047758-69047808 | AoSMC | blood vessel: | n/a |
21 | chr4:69047758-69047808 | H1-hESC | embryonic stem cell: | embryo |
22 | chr4:69048335-69048385 | HCF | heart: | n/a |
23 | chr4:69048335-69048385 | SK-N-SH_RA | brain: | n/a |
24 | chr4:69048335-69048385 | IMR90 | lung: | fetal |
25 | chr4:69048001-69048051 | SK-N-MC | brain: | n/a |
26 | chr4:69048335-69048385 | HRPEpiC | eye: | n/a |
27 | chr4:69048001-69048051 | K562 | blood: | n/a |
28 | chr4:69054755-69054805 | HCPEpiC | choroid plexus: | n/a |
29 | chr4:69048156-69048206 | GM12891 | blood: | n/a |
30 | chr4:69048001-69048051 | ECC-1 | luminal epithelium: | n/a |
31 | chr4:69048001-69048051 | PrEC | prostate: | n/a |
32 | chr4:69046856-69046906 | Jurkat | blood: | n/a |
33 | chr4:69048430-69048480 | GM06990 | blood: | n/a |
34 | chr4:69048001-69048051 | CMK | blood: | n/a |
35 | chr4:69048335-69048385 | CMK | blood: | n/a |
36 | chr4:69054755-69054805 | A549 | lung: | n/a |
37 | chr4:69046856-69046906 | HCF | heart: | n/a |
38 | chr4:69054755-69054805 | MCF-7 | breast: | n/a |
39 | chr4:69048430-69048480 | PANC-1 | pancreas: | n/a |
40 | chr4:69048233-69048283 | U87 | brain: | n/a |
41 | chr4:69054755-69054805 | SKMC | muscle: | n/a |
42 | chr4:69047758-69047808 | MCF-7 | breast: | n/a |
43 | chr4:69052173-69052223 | HL-60 | blood: | n/a |
44 | chr4:69048233-69048283 | HPAEpiC | pulmonary alveolar: | n/a |
45 | chr4:69048430-69048480 | Caco-2 | colon: | n/a |
46 | chr4:69046856-69046906 | HMEC | breast: | n/a |
47 | chr4:69048001-69048051 | A549 | lung: | n/a |
48 | chr4:69048233-69048283 | HEEpiC | esophagus: | n/a |
49 | chr4:69048430-69048480 | PFSK-1 | brain: | n/a |
50 | chr4:69048335-69048385 | HAEpiC | amniotic membrane: | n/a |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:68794052..68794960-chr4:69050850..69051709,2 | MCF-7 | breast: | |
2 | chr4:69078600..69080157-chr4:69085569..69088456,2 | MCF-7 | breast: | |
3 | chr4:69052749..69055570-chr4:69072267..69074922,2 | MCF-7 | breast: | |
4 | chr4:69052749..69055570-chr4:69072267..69074922,2 | MCF-7 | breast: | |
5 | chr4:69050039..69052225-chr4:69055143..69056998,2 | K562 | blood: | |
6 | chr4:68794157..68794866-chr4:69050816..69051359,2 | MCF-7 | breast: |
(count:8 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TMPRSS11BNL-1 | chr4:69078080-69078195 | NONHSAT096727 |
2 | lnc-TMPRSS11E-5 | chr4:69048010-69049221 | NR_015446 |
3 | lnc-TMPRSS11BNL-1 | chr4:69054121-69054474 | NONHSAT096726 |
4 | lnc-TMPRSS11E-5 | chr4:69051478-69051601 | NR_015446 |
5 | lnc-TMPRSS11BNL-1 | chr4:69071594-69071815 | NONHSAT096726 |
6 | lnc-TMPRSS11BNL-1 | chr4:69056739-69057034 | NONHSAT096727 |
7 | lnc-TMPRSS11E-5 | chr4:69078024-69078188 | NR_015446 |
8 | lnc-TMPRSS11BNL-1 | chr4:69071753-69071815 | NONHSAT096727 |
No data |
No data |
Variant related genes | Relation type |
---|---|
FTLP10 | TF binding region |
ENSG00000250026 | TF binding region |
FTLP10 | CpG island |
ENSG00000250026 | CpG island |
ENSG00000250026 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554009700 | chr4:69046654-69046655 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs573403202 | chr4:69046665-69046666 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs373218725 | chr4:69046672-69046673 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs12507309 | chr4:69046711-69046712 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs575570019 | chr4:69046743-69046744 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs544547897 | chr4:69046821-69046822 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs532314710 | chr4:69046856-69046857 | Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs564633581 | chr4:69046866-69046867 | Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs73823627 | chr4:69046998-69046999 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs552301477 | chr4:69047031-69047032 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs199615851 | chr4:69047052-69047053 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs17089132 | chr4:69047064-69047065 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs560289395 | chr4:69047077-69047078 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs140721136 | chr4:69047103-69047104 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs548818622 | chr4:69047119-69047120 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs373262555 | chr4:69047172-69047173 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs28519542 | chr4:69047215-69047216 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs551350048 | chr4:69047234-69047235 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs571618696 | chr4:69047308-69047309 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs386675558 | chr4:69047311-69047312 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs548735465 | chr4:69047381-69047382 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs184346418 | chr4:69047411-69047412 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs145363561 | chr4:69047438-69047439 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs567486156 | chr4:69047443-69047444 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs536420969 | chr4:69047450-69047451 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs77163928 | chr4:69047467-69047468 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs4860283 | chr4:69047516-69047517 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs547765807 | chr4:69047559-69047560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143520230 | chr4:69047597-69047598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2874105 | chr4:69047603-69047604 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs568582725 | chr4:69047646-69047647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375638276 | chr4:69047758-69047759 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs577943382 | chr4:69047767-69047768 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs540507523 | chr4:69047828-69047829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6835461 | chr4:69047910-69047911 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs137907332 | chr4:69047920-69047921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543168759 | chr4:69047930-69047931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547774921 | chr4:69047982-69047983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs17089133 | chr4:69048026-69048027 | ZNF genes & repeats Enhancers Weak transcription | CpG islandlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs141916273 | chr4:69048045-69048046 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs571087921 | chr4:69048066-69048067 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs374578208 | chr4:69048089-69048090 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs115051210 | chr4:69048097-69048098 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs368186529 | chr4:69048154-69048155 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs527245889 | chr4:69048168-69048169 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs547737628 | chr4:69048186-69048187 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs567519030 | chr4:69048192-69048193 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs73823628 | chr4:69048219-69048220 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs556313069 | chr4:69048232-69048233 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs569299752 | chr4:69048248-69048249 | ZNF genes & repeats Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 20369283 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Graft versus host disease | 20877625 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Osteoporosis | 20877625 | CNVD |
Osteoporosis | 19737800 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Oral cancer | 21386901 | CNVD |
Alcoholism | 21790672 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 19287141 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Ollier disease | 21235737 | CNVD |
Autism | 21865298 | CNVD |
Rett syndrome | 21593744 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Oligozoospermia | 20877625 | CNVD |
Sertoli-cell only syndrome | 20877625 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:69046600-69047200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
2 | chr4:69046600-69047400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr4:69046600-69047400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr4:69046600-69047400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr4:69046600-69047400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr4:69046600-69047400 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr4:69046600-69047400 | Enhancers | HMEC | breast |
8 | chr4:69046600-69047400 | Enhancers | NHEK | skin |
9 | chr4:69046600-69047800 | Enhancers | Hela-S3 | cervix |
10 | chr4:69046800-69047200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr4:69046800-69047400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr4:69046800-69047400 | Enhancers | A549 | lung |
13 | chr4:69046800-69047800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr4:69047400-69048800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr4:69047800-69048800 | Weak transcription | Hela-S3 | cervix |
16 | chr4:69048000-69048400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr4:69048000-69048400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr4:69048000-69048600 | Enhancers | Esophagus | oesophagus |
19 | chr4:69048600-69054400 | Weak transcription | Esophagus | oesophagus |
20 | chr4:69048800-69049200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
21 | chr4:69048800-69050000 | Enhancers | Hela-S3 | cervix |
22 | chr4:69080200-69081000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
23 | chr4:69080400-69084200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
24 | chr4:69080800-69081000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
25 | chr4:69080800-69081000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
26 | chr4:69081000-69082000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
27 | chr4:69081000-69082000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
28 | chr4:69081000-69082200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
29 | chr4:69081200-69081400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |